CompletedPhase 1NCT03855696

A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients

Studying Hemophilia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Green Cross Corporation
Principal Investigator
Ji-Young Park, MD
Korea University Anam Hospital
Intervention
MG1113(biological)
Enrollment
41 enrolled
Eligibility
19-60 years · MALE
Timeline
2019 – 2021

Study locations (2)

Collaborators

Dream CIS, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03855696 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials